Bcal Diagnostics Share Price and Company Fundamentals
Last traded: Today at 5:31 AM
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
7.61
Dividend yield
Beta
-
Market cap
$36.2M
Enterprise value
$24.59M
Company profile
| Primary activities | BCAL Diagnostics Limited is a biotechnology company developing a blood based diagnostic test for breast cancer. |
|---|---|
| Industry / Sector | Diagnostics & Research / Healthcare |
| Website | http://www.bcaldiagnostics.com |
| Mailing address | 50 Clarence Street Suite 506 Level 5 Sydney NSW 2000 Australia |
| Phone / Fax | 61 2 9078 7671 / |
| Share registry | AUTOMIC REGISTRY SERVICES |
Dividends
Bcal Diagnostics does not pay dividends.
Company Executives
As of Sep 2021, following are the company executives and directors listed on Bcal Diagnostics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Ms. Jayne Andrea Shaw | Co-Founder & Exec. Chairman | ||
| Hon. Ronald Anthony Phillips A.O. | Co-Founder & Non-Exec. Director | ||
| Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD | CFO & Company Sec. | ||
| Dr. Jane Ryan | Chief Operating Officer | ||
| Sean Kennedy | Director of Corp. Fin. | ||
| Ms. Rebecca Shaw | Marketing Mang. | ||
| Dr. Amani Batarseh Ph.D. | Chief Scientist Officer |
Profitability and management effectiveness
Profit margin
0.00%
Operating margin
-339.66%
Return on assets
-23.60%
Return on equity
-75.39%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Bcal Diagnostics is 36.2M and its enterprise value is 24.59M. The enterprise value to revenue ratio of BDX is 89.35.
Companies similar to Bcal Diagnostics (BDX)
Bcal Diagnostics (ASX:BDX) Frequently Asked Questions
1. What is Bcal Diagnostics's Stock Symbol?
Bcal Diagnostics trades on ASX under the ticker symbol "BDX".
2. What is Bcal Diagnostics's stock price today?
One share of BDX stock can currently be purchased for approximately $0.175.
3. How can I contact Bcal Diagnostics?
Bcal Diagnostics's mailing address is 50 Clarence Street Suite 506 Level 5 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9078 7671.
4. What is Bcal Diagnostics's official website?
The official website of Bcal Diagnostics is http://www.bcaldiagnostics.com.
5. Which share registry manages Bcal Diagnostics's stock?
Bcal Diagnostics's stock is managed by AUTOMIC REGISTRY SERVICES.